GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
RESEARCH TRIANGLE PARK, N.C., May 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline plc (NYSE: GSK ) today announced that it has entered into an agreement to divest full commercial rights to Wellbutrin
XL (R) in the United States to Biovail International Laboratories SRL, a subsidiary of Biovail Co...
Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S.
MORRISTOWN, N.J., Dec. 1 /PRNewswire/ -- Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 150mg. Distribution of the product ...
Watson Pharmaceuticals Receives FDA Final Approval for Generic Wellbutrin XL(R) 150 mg
CORONA, Calif., Nov. 26 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals,
Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced
that its subsidiary, Watson Laboratories, Inc., has received final approval
today from the United States Food and Drug Administration on its Ab...
Actavis Receives Approval of Generic Wellbutrin XL(R) 300mg in the U.S.
MORRISTOWN, N.J., Aug. 18 /PRNewswire/ -- Actavis Group, the
international generic pharmaceuticals company, today announced that it has
received approval from the U.S. Food & Drug Administration to market
Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution
of the product ...
Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
...line in royalties from Sandoz's sales of metoprolol succinate extended-release tablets 50mg and a decline in royalties from GlaxoSmithKline's sales of wellbutrin
Generic gross profit was $163.2 million in the first quarter of 2009, compared to $137.0 million in the first quarter of 2008 and $153.0 ...
Aplenzin(TM), the Only Single Tablet Once-Daily Treatment for Depression at All Doses, Now Available in the United States
...n patients who have a seizure disorder, patients being treated with Zyban(R) (bupropion HCl) Sustained-Release Tablets, WELLBUTRIN(R) (bupropion HCl), wellbutrin
SR(R) (bupropion HCl) Sustained-Release Tablets, or any other medications that contain bupropion, patients who have or had bulimia or anorexia nervosa...
Diabetes Drugs Emerge as Top Force in Drug Spending Growth
...se conditions; * An 8.4 percent decrease in spending on antidepressants reflects a decline in unit costs with generic versions of Zoloft(R) and wellbutrin
XL(R) entering the market. The use of antidepressants increased slowly during 2007, which may continue to reflect concerns about the possible ...
Antidepressant Effectiveness Probably Overstated: Report
...he increase in the effectiveness of the drug ranged from 11 percent to 69 percent for individual drugs, and was 32 percent overall. The antidepressant wellbutrin
appeared to show a high level of bias.
The authors also noted that studies that were not positive were often published with a slant that made them ...
GlaxoSmithKline Presents Innovative Neuroscience Pipeline
Seretide TORCH Volibris (EU) Ofatumumab (RA) (EU)
Tykerb (US) Requip XL (PD) (US) Promacta (hep c)
XR (EU) Rotarix (US) Tykerb (H&N cancer)
Tykerb + Pazopanib ...
New Report Provides Insight Into Developments in the Market for Anxiety and Depression Therapies
...s report include: Effexor (venlafaxine;
Wyeth), Lexapro (escitalopram; Forest), Pristiq (o-desmethylvenlafaxine;
Wyeth), Cymbalta (duloxetine; Lilly), wellbutrin
GlaxoSmithKline), Valdoxan (agomelatine; Novartis/Servier), bifeprunox
(Wyeth/Solvay/ Lundbeck), Seroquel (quietiapine; AstraZeneca), amib...